IAPP and Parkinson disease: This review has largely focused on Aβ from Alzheimer's and its impact on membranes and cytotoxicity, but many of the observations described in this review draw parallels with the impact of other amyloid protein oligomers on the membrane.[32, 33] Examples include: α‐Synuclein from Parkinson's disease;[30, 148] Amylin, or islet amyloid polypeptide (IAPP) for diabetes;[31, 149] β2macroglobulin (β2M);[76] serum amyloid‐A[77] and mammalian prion protein.[150] Furthermore, many of the impacts Aβ has on the membrane are similar to the action of anti‐microbial peptides.[17b, 34, 35, 36, 151]